China Nuclear Imaging Market Revenues to Reach USD 409.14 million by 2028

Hyderabad, Aug. 14, 2023 (WORLD NEWSWIRE) — According to a brand-new marketing research report entitled “China Nuclear Imaging Market Report (2023-2028),” the marketplace is approximated at USD 334.51 million in 2023. It is anticipated to sign up a CAGR of 4.11% throughout the projection duration.

Chronic illness like dementia are a considerable issue in China, for which nuclear imaging strategies are utilized for medical diagnosis. The frequency of dementia in areas like Xiamen, China, has actually caused a greater need for nuclear imaging. The Chinese nuclear imaging market is driven by the increasing concern of persistent illness, technological improvements, and development in nuclear medication and imaging applications, to name a few elements. China’s concentrate on nuclear medication and imaging appears from the establishment of brand-new centers for radioisotope research study. The intro of brand-new nuclear medication research study centers and increased radioisotope production is anticipated to drive the development of the marketplace in the coming years.

Report Summary:

Who are the Top Companies in the China Nuclear Imaging Market?

The market has actually been seeing technological advancements on a big scale for the previous number of years. Major gamers are concentrating on R&D to enhance their market position.

The substantial gamers in the Chinese nuclear imaging market are,

• Bayer AG

• Bracco Imaging HEALTH CLUB

• Canon Inc.

• Cardinal Health Inc.

• China Isotope & Radiation Corporation (CIRC)

• Curium Pharma

• General Electric Company (GE HealthCare)

• Global Medical Solutions Ltd

• Koninklijke Philips NV

• Siemens Healthcare GmbH

• Yantai Dongcheng Pharmaceutical Group Co. Ltd

Story continues

Other Reports That Might Be of Your Interest:

• North America Nuclear Imaging Market Report – The North American nuclear imaging market size is approximated at USD 3.63 billion in 2023. It is anticipated to reach USD 4.38 billion by 2028, at a CAGR of 3.83% throughout the projection duration (2023-2028).

• Europe Nuclear Imaging Market Report – The European nuclear imaging market size is approximated at USD 2.15 billion in 2023. It is anticipated to reach USD 2.54 billion by 2028, at a CAGR of 3.34% throughout the projection duration (2023-2028).

Key Highlights from the China Nuclear Imaging Market Report:

Neurology Under SPECT Application Segment to Grow Significantly

• The market for Single Photon Emission Computed Tomography (SPECT) applications in neurology is experiencing development in China due to the high frequency of neurological and brain conditions.

• Neurological problems like Parkinson’s illness (PD) prevail in the nation, and there is a growing requirement for precise diagnostic tools.

• Research research studies carried out in China are more verifying the efficiency of SPECT imaging. High uniqueness and level of sensitivity in SPECT scans increase their energy and dependability for detecting neurological conditions, motivating their use and development.

Oncology Under FAMILY PET Application Segment to Witness High Growth

• Positron Emission Tomography (FAMILY PET) is a nuclear medication treatment that determines the metabolic activity of body tissue cells, integrating nuclear medication and biochemical analysis. It is mostly utilized for detecting numerous kinds of cancers and is progressively used for cancer phenotyping, allowing vivo characterization of cancer.

• The combination of oncology and animal imaging has actually caused sophisticated cancer examination strategies, allowing more exact cancer phenotyping and characterization.

• Advancements in animal innovation, combined with continuous research study studies, are anticipated to result in brand-new applications in oncology, adding to the development of the Chinese nuclear imaging market.

What are the Latest Developments in the China Nuclear Imaging Market?

• In August 2022, Ion Beam Applications SA signed a cooperation contract with Chengdu New Radiomedicine Technology Co. Ltd (CNRT) to set up a Cyclone IKON in Chengdu, Sichuan Province, China.

• In January 2022, ImaginAb and DongCheng Pharmaceutical Group formed a collaboration to bring ImaginAb’s CD8 ImmunoPET representative, zirconium Zr 89 crefmirlimab berdoxam item, into the Chinese market.

Mordor Intelligence has Segmented the China Nuclear Imaging Market Based on Product and Application.

• By Product (Market Size and Forecast based upon Value (USD billion), 2018-2028)

  • Equipment

  • Radioisotope

    • SPECT Radioisotopes

    • FAMILY PET Radioisotopes

      • Fluorine-18 (F-18)

      • Rubidium-82 (RB-82)

      • Other FAMILY PET Radioisotopes

• By Application (Market Size and Forecast based upon Value (USD billion), 2018-2028)

  • SPECT Applications

    • Neurology

    • Cardiology

    • Thyroid

    • Other SPECT Applications

  • FAMILY PET Applications

    • Oncology

    • Cardiology

    • Neurology

    • Other FAMILY PET Applications

In a nutshell, the Mordor Intelligence marketing research report is a must-read for start-ups, market gamers, financiers, scientists, specialists, business strategists, and all those who are seeking to comprehend this market. Get a glimpse at the China Nuclear Imaging Market Report (2023-2028).

Mordor Intelligence continuously tracks market patterns. Some pertinent market reports from the experts that may be of interest to you:

• Asia-Pacific Nuclear Imaging Market Report – The Asia-Pacific nuclear imaging market size is approximated at USD 1.46 billion in 2023. It is anticipated to reach USD 1.80 billion by 2028, at a CAGR of 4.23% throughout the projection duration (2023-2028).

• South America Nuclear Imaging Market Report – The South American nuclear imaging market size is approximated at USD 407.61 million in 2023. It is anticipated to reach USD 471.84 million by 2028, at a CAGR of 2.97% throughout the projection duration (2023-2028).

• Middle East & Africa Nuclear Imaging Market Report – The Middle East & Africa nuclear imaging market size is anticipated to grow from USD 285.30 million in 2023 to USD 324.37 million by 2028, at a CAGR of 2.60% throughout the projection duration (2023-2028).

About Mordor Intelligence:

Mordor Intelligence is a market intelligence and advisory company. At Mordor Intelligence, our company believe in anticipating butterfly impacts that have the possible to alter or substantially effect market characteristics.

Our marketing research reports are thorough and supply special information, realities and figures, patterns, and the competitive landscape of the market.

Attachment

CONTACT: Company Name: Mordor Intelligence Email: [email protected] Phone: +1 617-765-2493 Location: Hyderabad, Telangana Country: India